Researchers studied more than 38,000 participants 65 years old and older from 823 nursing homes. They compared the use of two influenza vaccines: one high dose and the other a standard vaccine. The residents received the vaccines in fall of 2013.
The study shows the high-dose vaccine reduced hospitalization for respiratory illness by 12.7 percent compared to the standard-dose vaccine. It also reduced all-cause hospitalizations among residents by 8.5 percent.
“In our study, we estimated that for every 84 individuals receiving the high dose vaccine a person was prevented from being hospitalized during the influenza season,” said Stefan Gravenstein, MD, lead author of the study and faculty member at Providence, R.I.-based Warren Alpert Medical School at Brown University; University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine in Cleveland.
More articles on infection control:
16 multistate Salmonella outbreaks linked to microbiology labs
Saliva, blood tests comparable for diagnosing hep E, study shows
Texas health officials warn providers of rise in parasitic infections
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.